Literature DB >> 9556087

Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease.

L C von Hertzen1.   

Abstract

The diverging of T-helper (Th) cells into predominantly Th1 and Th2 subsets on the basis of their cytokine profiles has decisively improved our understanding of the pathogenesis of many chronic infectious diseases. Recent data suggest that the presence of interferon-gamma and the subsequent suppression of interleukin-4 production leads to a Th1-type response that is required for the resolution of infections caused by intracellular pathogens. The ability of the macrophages to respond aggressively during early antigen contact seems to be one crucial factor in the development of an appropriate Th-cell response. Several host-related factors can affect macrophage function and the polarization of T-cell responses, ie the shift from a Th1 response to a Th2 one, and thus dramatically deteriorate the resolution of infections caused by intracellular agents such as Chlamydia pneumoniae. Chronic C. pneumoniae infection has been associated with several common chronic diseases, quite recently with chronic obstructive pulmonary disease. Chronic C. pneumoniae infection may amplify smoking-associated inflammation in the bronchi and may be a contributory factor in the development of irreversible pathological changes.

Entities:  

Mesh:

Year:  1998        PMID: 9556087     DOI: 10.3109/07853899808999382

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

1.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

Authors:  C Scott Little; Andrew Bowe; Richard Lin; Jason Litsky; Robert M Fogel; Brian J Balin; Kerin L Fresa-Dillon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles.

Authors:  I Puljiz; I Kuzman; O Dakovic-Rode; N Schönwald; B Mise
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

4.  Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.

Authors:  F Blasi; S Damato; R Cosentini; P Tarsia; R Raccanelli; S Centanni; L Allegra
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

5.  Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype.

Authors:  Doriane Calmes; Pascale Huynen; Virginie Paulus; Monique Henket; Françoise Guissard; Catherine Moermans; Renaud Louis; Florence Schleich
Journal:  Respir Res       Date:  2021-02-26

6.  Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies.

Authors:  Olfa Frikha-Gargouri; Radhouane Gdoura; Abir Znazen; Nozha Ben Arab; Jalel Gargouri; Mounir Ben Jemaa; Adnene Hammami
Journal:  BMC Infect Dis       Date:  2008-07-26       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.